Literature DB >> 10473459

Pituitary surgery for acromegaly. Should be done by specialists.

R N Clayton, P M Stewart, S M Shalet, J A Wass.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10473459      PMCID： PMC1116477          DOI： 10.1136/bmj.319.7210.588

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon.

Authors:  N J Gittoes; M C Sheppard; A P Johnson; P M Stewart
Journal:  QJM       Date:  1999-12

2.  Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.

Authors:  A Abosch; J B Tyrrell; K R Lamborn; L T Hannegan; C B Applebury; C B Wilson
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

Review 3.  The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.

Authors:  C A Lissett; S R Peacey; I Laing; L Tetlow; J R Davis; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

4.  Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome.

Authors:  S Yamada; T Aiba; K Takada; Y Ozawa; T Shimizu; S Sawano; Y Shishiba; T Sano
Journal:  Clin Endocrinol (Oxf)       Date:  1996-09       Impact factor: 3.478

5.  Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.

Authors:  R Sheaves; P Jenkins; P Blackburn; A H Huneidi; F Afshar; S Medbak; A B Grossman; G M Besser; J A Wass
Journal:  Clin Endocrinol (Oxf)       Date:  1996-10       Impact factor: 3.478

6.  Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

Authors:  S M Orme; R J McNally; R A Cartwright; P E Belchetz
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

7.  An audit of outcome of treatment in acromegaly.

Authors:  A S Bates; W Van't Hoff; J M Jones; R N Clayton
Journal:  Q J Med       Date:  1993-05

8.  The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly.

Authors:  D Jenkins; I O'Brien; A Johnson; R Shakespear; M C Sheppard; P M Stewart
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

9.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  Factors determining the long-term outcome of surgery for acromegaly.

Authors:  I A Osman; R A James; S Chatterjee; D Mathias; P Kendall-Taylor
Journal:  QJM       Date:  1994-10
View more
  8 in total

Review 1.  Treatment of pituitary tumors: surgery.

Authors:  Michael Buchfelder
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

2.  Determinants of neurosurgical outcome in pituitary tumors.

Authors:  M J Barahona; L Sojo; A M Wägner; F Bartumeus; B Oliver; P Cano; S M Webb
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

Review 3.  The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective.

Authors:  Pietro Mortini; Gianluca Nocera; Francesca Roncelli; Marco Losa; Anna Maria Formenti; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 4.  The surgical treatment of acromegaly.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

5.  Multi-modal management of acromegaly: a value perspective.

Authors:  Kristopher T Kimmell; Robert J Weil; Nicholas F Marko
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

6.  The effect of MR contrast medium dose on pituitary gland enhancement, microlesion enhancement and pituitary gland-to-lesion contrast conspicuity.

Authors:  Walter S Bartynski; John F Boardman; Stephen Z Grahovac
Journal:  Neuroradiology       Date:  2006-05-03       Impact factor: 2.804

Review 7.  Excess mortality for patients with residual disease following resection of pituitary adenomas.

Authors:  Michael E Sughrue; Edward F Chang; Rodney A Gabriel; Manish K Aghi; Lewis S Blevins
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

8.  Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications.

Authors:  Yvette Marquez; Alexander Tuchman; Gabriel Zada
Journal:  Int J Endocrinol       Date:  2012-03-01       Impact factor: 3.257
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.